These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36650958)

  • 21. Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Annoussamy M; Mayer M; Maincent K; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(4):e0121799. PubMed ID: 25861036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Turkish version of the Motor Function Measure Scale (MFM-32) forneuromuscular diseases: a cross-cultural adaptation, reliability, and validity study.
    İnal HS; Tarakçı E; Tarakçı D; Aksoy G; Mergen Kılıç S; Beşer H; Beşer Ç; Özdinçler AR; Durmuş Tekçe H; Parman FY; Deymeer F; Oflazer ZP
    Turk J Med Sci; 2017 Dec; 47(6):1826-1833. PubMed ID: 29306245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of the SMA independence scale-upper limb module (SMAIS-ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA.
    Trundell D; Skalicky A; Staunton H; Hareendran A; Le Scouiller S; Barrett L; Cooper O; Gorni K; Seabrook T; Jethwa S; Cano S
    J Neurol Sci; 2022 Jan; 432():120059. PubMed ID: 34896922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and effectiveness of a novel dynamic arm support in persons with spinal muscular atrophy and duchenne muscular dystrophy.
    Janssen MMHP; Horstik J; Klap P; de Groot IJM
    J Neuroeng Rehabil; 2021 May; 18(1):84. PubMed ID: 34020668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests.
    Bartels B; de Groot JF; Habets LE; Wijngaarde CA; Vink W; Stam M; Asselman FL; van Eijk RPA; van der Pol WL
    Orphanet J Rare Dis; 2020 Mar; 15(1):75. PubMed ID: 32293503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual abilities, language comprehension, speech, and motor function in children with spinal muscular atrophy type 1.
    Zappa G; LoMauro A; Baranello G; Cavallo E; Corti P; Mastella C; Costantino MA
    J Neurodev Disord; 2021 Feb; 13(1):9. PubMed ID: 33530934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes.
    Sivo S; Mazzone E; Antonaci L; De Sanctis R; Fanelli L; Palermo C; Montes J; Pane M; Mercuri E
    Neuromuscul Disord; 2015 Mar; 25(3):212-5. PubMed ID: 25500010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure.
    Vuillerot C; Girardot F; Payan C; Fermanian J; Iwaz J; De Lattre C; Berard C
    Dev Med Child Neurol; 2010 Jan; 52(1):60-5. PubMed ID: 19453691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor function measure: validation of a short form for young children with neuromuscular diseases.
    de Lattre C; Payan C; Vuillerot C; Rippert P; de Castro D; Bérard C; Poirot I;
    Arch Phys Med Rehabil; 2013 Nov; 94(11):2218-26. PubMed ID: 23602884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revised upper limb module for spinal muscular atrophy: 12 month changes.
    Pera MC; Coratti G; Mazzone ES; Montes J; Scoto M; De Sanctis R; Main M; Mayhew A; Muni Lofra R; Dunaway Young S; Glanzman AM; Duong T; Pasternak A; Ramsey D; Darras B; Day JW; Finkel RS; De Vivo DC; Sormani MP; Bovis F; Straub V; Muntoni F; Pane M; Mercuri E;
    Muscle Nerve; 2019 Apr; 59(4):426-430. PubMed ID: 30677148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of motor function and nutritional status in children with spinal muscular atrophy treated with nusinersen after loading period in Western China: a retrospective study.
    Yang H; Tao Q; Li D; Yang J; Cai Q; Gan J; Huang S; Luo R
    BMC Neurol; 2023 Jan; 23(1):35. PubMed ID: 36690929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth patterns in children with spinal muscular atrophy.
    De Amicis R; Baranello G; Foppiani A; Leone A; Battezzati A; Bedogni G; Ravella S; Giaquinto E; Mastella C; Agosto C; Bertini E; D'Amico A; Pedemonte M; Bruno C; Wells JC; Fewtrell M; Bertoli S
    Orphanet J Rare Dis; 2021 Sep; 16(1):375. PubMed ID: 34481516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity and reliability of the Selective Control of the Upper Extremity Scale in children with upper motor neuron lesions.
    Lieber J; Gartmann T; Keller JW; van Hedel HJA
    Disabil Rehabil; 2022 Jul; 44(14):3694-3700. PubMed ID: 33577357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.
    Suslov V; Suslova G; Lytaev S
    Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical Disease Progression Modeling in Type 2/3 Spinal Muscular Atrophy.
    Jacqmin P; Gieschke R; Delor I; Snoeck E; Vianna E; Vuillerot C; Sanwald Ducray P
    Muscle Nerve; 2018 Oct; 58(4):528-535. PubMed ID: 29938801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy.
    Fragala-Pinkham M; Pasternak A; McDermott MP; Mirek E; Glanzman AM; Montes J; Dunaway Young S; Salazar R; Quigley J; Riley SO; Chiriboga CA; Finkel RS; Tennekoon G; Martens WB; De Vivo DC; Darras BT
    J Pediatr Rehabil Med; 2021; 14(3):451-461. PubMed ID: 34275913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study.
    Lefeuvre C; Brisset M; Sarlon M; Petit N; Orlikowski D; Clair B; Thiry T; Carlier RY; Prigent H; Nicolas G; Annane D; Laforet P; Pouplin S
    Rev Neurol (Paris); 2022 Mar; 178(3):234-240. PubMed ID: 35000792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different trajectories in upper limb and gross motor function in spinal muscular atrophy.
    Coratti G; Pera MC; Montes J; Pasternak A; Scoto M; Baranello G; Messina S; Dunaway Young S; Glanzman AM; Duong T; De Sanctis R; Mazzone ES; Milev E; Rohwer A; Civitello M; Pane M; Antonaci L; Frongia AL; Sframeli M; Vita GL; DʼAmico A; Mizzoni I; Albamonte E; Darras BT; Bertini E; Sansone VA; Bovis F; Day J; Bruno C; Muntoni F; De Vivo DC; Finkel R; Mercuri E
    Muscle Nerve; 2021 Nov; 64(5):552-559. PubMed ID: 34327716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability and validity of the Turkish version of the Upper Limb Short Questionnaire in Duchenne muscular dystrophy.
    Savaş D; Tarsuslu T
    Somatosens Mot Res; 2023 Jun; 40(2):56-61. PubMed ID: 36538388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.